As many as 21 million people worldwide inject drugs, putting them at heightened risk for infection from blood-borne pathogens such as the hepatitis C virus (HCV), especially if syringes are shared.
A newer type of syringe designed to reduce HCV transmission by decreasing the so-called dead space—the volume that exists between the syringe hub and needle in comparison to standard and widely used high dead space designs—is not particularly effective, a new Yale School of Public Health-led study has found.
The research is published today in the journal PLOS ONE.
Read more....
Showing posts with label LDS Syringes. Show all posts
Showing posts with label LDS Syringes. Show all posts
Wednesday, November 4, 2015
Subscribe to:
Posts (Atom)